Fig. 3.
Phenotypical analysis of human thymocytes recovered from NOD/SCID mice.
Conditioning indicates radiotherapy + TM-β1. Unless otherwise indicated, gates were set on viable human CD45+ cells (A, B, C, E, H, I). Within this population subsequent maturational stages were identified: CD4+CD8+ (68%), CD3+CD69+ (13%), CD3+CD27+ (7%), and CD3+CD1− (2%). Virtually all CD3+cells were TCR-αβ+. (D) Gated on CD45+CD3+ cells. (F, G) Gated on CD3+CD1− cells, as indicated.